Miami, FLNCT06402201Now EnrollingIRB Ready

Select Advanced Solid Tumors Clinical Trial in Miami, FL

Access cutting-edge select advanced solid tumors treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.

Sponsored by CDR-Life AG

Quick Self-Assessment

See if you qualify for this Miami location

Preparing your pre-screening questions…

Expert Care in Miami

Access select advanced solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related select advanced solid tumors treatment provided free

Apply for This Miami Location

Check if you qualify for this select advanced solid tumors clinical trial in Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami site if eligible
  4. 4Begin participation

About This Select Advanced Solid Tumors Study in Miami

CDR404 is a highly potent and specific T-cell engaging bispecific and bivalent antibody designed for the treatment of cancers positive for the tumor-associated antigen melanoma-associated antigen 4 (MAGE-A4). This is a first-in-human study designed to evaluate the safety, tolerability, and preliminary anti-tumor activity of CDR404 in adult patients who have the appropriate germline human leukocyte antigen HLA-A\*02:01 tissue marker and whose cancer is positive for MAGE-A4.

Sponsor: CDR-Life AG

Who Can Participate

Inclusion Criteria

Provision of written informed consent
HLA-A\*02:01 positive
MAGE-A4 positive tumor
Eastern Cooperative Oncology Group (ECOG) performance status (PS) \[ECOG PS\] 0 or 1
Selected advanced solid tumors
Relapsed from, refractory to, or intolerant of standard therapy
Measurable disease per RECIST v1.1
Adequate organ function
If applicable, must agree to use highly effective contraception

Exclusion Criteria

Symptomatic or untreated central nervous system metastasis
Inadequate washout from prior anticancer therapy
Significant ongoing toxicity from prior anticancer treatment
Recent surgery
Clinically significant cardiac disease
Active infection requiring systemic antibiotic treatment
Human immunodeficiency virus (HIV) at risk of acquired immunodeficiency syndrome (AIDS)-related outcomes
Active hepatitis B virus (HBV) or hepatitis C virus (HBC)
Ongoing treatment with systemic steroids or other immunosuppressive therapies
Significant secondary malignancy
History of chronic or recurrent active autoimmune disease requiring treatment
Uncontrolled intercurrent illness
Pregnancy or lactation.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami?

Yes, this clinical trial (NCT06402201) has an active research site in Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Select Advanced Solid Tumors Treatment Options in Miami, FL

If you're searching for select advanced solid tumors treatment options in Miami, FL, this clinical trial (NCT06402201) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced select advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all select advanced solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Miami, FL

See all advanced solid tumors clinical trials recruiting in Miami — not just this study.

Browse Advanced Solid Tumors Trials in Miami

Ready to Join in Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami, FL